awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38706993-6482D226-616A-440A-B416-C69A1D44723F
Q38706993-6482D226-616A-440A-B416-C69A1D44723F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38706993-6482D226-616A-440A-B416-C69A1D44723F
Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma.
P2860
Q38706993-6482D226-616A-440A-B416-C69A1D44723F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38706993-6482D226-616A-440A-B416-C69A1D44723F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
06bb91c2ea6ac8f6ad808a2eb3ff5798d8371f32
P2860
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.